Nomura Holdings Inc. purchased a new stake in shares of Hill-Rom Holdings Inc (NYSE:HRC) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 4,177 shares of the medical technology company’s stock, valued at approximately $332,000.

A number of other large investors have also recently modified their holdings of the business. 361 Capital LLC lifted its holdings in Hill-Rom Holdings by 68.3% during the second quarter. 361 Capital LLC now owns 22,886 shares of the medical technology company’s stock valued at $1,822,000 after purchasing an additional 9,287 shares in the last quarter. The Manufacturers Life Insurance Company lifted its holdings in Hill-Rom Holdings by 2.4% during the second quarter. The Manufacturers Life Insurance Company now owns 88,036 shares of the medical technology company’s stock valued at $7,009,000 after purchasing an additional 2,032 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in Hill-Rom Holdings by 304.8% during the second quarter. Arrowstreet Capital Limited Partnership now owns 202,001 shares of the medical technology company’s stock valued at $16,081,000 after purchasing an additional 152,101 shares in the last quarter. Caxton Associates LP lifted its holdings in Hill-Rom Holdings by 13.8% during the second quarter. Caxton Associates LP now owns 6,600 shares of the medical technology company’s stock valued at $525,000 after purchasing an additional 800 shares in the last quarter. Finally, Cubist Systematic Strategies LLC lifted its holdings in Hill-Rom Holdings by 5,480.5% during the second quarter. Cubist Systematic Strategies LLC now owns 11,161 shares of the medical technology company’s stock valued at $889,000 after purchasing an additional 10,961 shares in the last quarter. 82.31% of the stock is currently owned by institutional investors and hedge funds.

Hill-Rom Holdings Inc (NYSE:HRC) opened at 81.19 on Monday. The stock has a market cap of $5.35 billion, a P/E ratio of 47.31 and a beta of 1.19. The stock has a 50 day moving average of $76.37 and a 200 day moving average of $76.46. Hill-Rom Holdings Inc has a 12-month low of $50.50 and a 12-month high of $84.65.

Hill-Rom Holdings (NYSE:HRC) last released its quarterly earnings results on Friday, July 28th. The medical technology company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Hill-Rom Holdings had a net margin of 4.27% and a return on equity of 19.99%. The firm had revenue of $689.10 million for the quarter, compared to analysts’ expectations of $695.50 million. During the same quarter last year, the company earned $0.81 EPS. The firm’s revenue for the quarter was up 5.1% compared to the same quarter last year. On average, equities research analysts anticipate that Hill-Rom Holdings Inc will post $3.82 earnings per share for the current fiscal year.

In related news, SVP Andreas G. Frank sold 6,870 shares of Hill-Rom Holdings stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $77.48, for a total value of $532,287.60. Following the sale, the senior vice president now owns 16,701 shares of the company’s stock, valued at approximately $1,293,993.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Andreas G. Frank sold 3,940 shares of Hill-Rom Holdings stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $77.84, for a total transaction of $306,689.60. Following the completion of the sale, the senior vice president now directly owns 16,701 shares in the company, valued at approximately $1,300,005.84. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION NOTICE: This piece was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another domain, it was stolen and reposted in violation of international trademark & copyright laws. The correct version of this piece can be viewed at https://www.watchlistnews.com/nomura-holdings-inc-invests-332000-in-hill-rom-holdings-inc-hrc-stock/1649255.html.

Several research firms have recently commented on HRC. BidaskClub downgraded shares of Hill-Rom Holdings from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Zacks Investment Research downgraded shares of Hill-Rom Holdings from a “buy” rating to a “hold” rating in a report on Tuesday, July 11th. Morgan Stanley boosted their target price on shares of Hill-Rom Holdings from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Friday, June 30th. Stifel Nicolaus reissued a “buy” rating and issued a $84.00 target price on shares of Hill-Rom Holdings in a report on Sunday, July 30th. Finally, Cantor Fitzgerald set a $86.00 target price on shares of Hill-Rom Holdings and gave the stock a “hold” rating in a report on Friday, July 28th. Three analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $86.83.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.